Directly Or Indirectly Stimulating Motor Muscles Patents (Class 607/48)
  • Patent number: 10493282
    Abstract: Therapy systems for treating a patient are disclosed. Representative therapy systems include an implantable pulse generator, a signal delivery device electrically coupled to the pulse generator, and a remote control in electrical communication with the implantable pulse generator. The pulse generator can have a computer-readable medium containing instructions for performing a process that comprises collecting the patient status and stimulation parameter; analyzing the collected patient status and stimulation parameter; and establishing a preference baseline containing a preferred stimulation parameter corresponding to a particular patient status.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: December 3, 2019
    Assignee: Nevro Corp.
    Inventors: Anthony V. Caparso, Jon Parker, Andre B. Walker, Yougandh Chitre
  • Patent number: 10485440
    Abstract: A bioelectric interface for monitoring, detection and transmission of detected ECG data is provided comprising a sensory system for detecting bio-physiological measurements utilizing spatially resolved potential profiles obtained from a localized cluster of sub-electrodes to form constituent sets of miniature sensor arrays. Using only a single macro-electrode, two or more sets of sub-electrode arrays are used to measure bipolar spatial gradients obtained from measured cardiac potentials. The sets of sub-electrodes containing the clusters are optimized to attain measurable gradients of diagnostic value. A minimax procedure allows bio-potential sensory acquisition through a bi-directional digital steering process, which essentially comprises monitoring, detection, selection, grouping, recording and transmission of ECG waveform characteristic data.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: November 26, 2019
    Assignee: Global Cardiac Monitors, Inc.
    Inventor: Karim Alhussiny
  • Patent number: 10478623
    Abstract: System and methods for monitoring and/or controlling nerve activity in a subject are provided. In one embodiment, a system includes electrodes configured to be placed proximate to a subject's skin, and a signal detector configured to detect electrical signals using the electrodes. The system also includes a signal processor configured to receive the electrical signals from the signal detector, and apply a filter to the received electrical signals to generate filtered signals, the filter configured to attenuate at least signals having frequencies corresponding to heart muscle activity during a heartbeat. The signal processor is also configured to identify a skin nerve activity using the filtered signals, estimate a sympathetic nerve activity using the identified skin nerve activity, and further to generate a report indicative of the estimated sympathetic nerve activity. In some aspects, the system further includes a signal generator to deliver the electrical stimulation to the subject's skin.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: November 19, 2019
    Assignee: Indiana University Research and Technology Corporation
    Inventor: Peng-Sheng Chen
  • Patent number: 10449382
    Abstract: An implantable subsystem includes multiple implantable neural probes disposed on a flexible substrate. Each neural probe is configured to magnetically stimulate brain neurons. Each probe includes an array of magnetic neural stimulators that magnetically stimulate neurons. Each probe also includes neural probe activation circuitry comprising thin film switches disposed on the flexible substrate. The thin film switches are electrically coupled to row and column activation lines and selectively activate the magnetic neural stimulators in response to neural stimulation activation signals carried on the activation lines.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: October 22, 2019
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Bernard D. Casse, George Daniel, Jonathan Rivnay, Christopher Paulson, Robert Street
  • Patent number: 10441788
    Abstract: Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a lead body that attaches to a portion of the adrenal gland of the patient; and a plurality of electrodes arranged along the lead body. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: October 15, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Lynne E. Swanson, William C. Stoffregen, Bryan A. Clark, Michael X. Govea, Dennis B. Werner, Natalie A. Brill, Pramodsingh H. Thakur
  • Patent number: 10426900
    Abstract: A method for measuring an amount of pain involves positioning a needle adjacent a non-human animal which is under anesthesia, inserting the needle at a controlled puncture speed into skin of the non-human animal, and measuring a muscle action potential of a muscle portion of the non-human animal produced by the insertion of the needle. The muscle action potential is measured from insertion start, at which the insertion of the needle into the skin is started, to insertion stop, at which the insertion of the needle into the skin is stopped.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: October 1, 2019
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventors: Kazuo Okamoto, Nozomi Ami, Tadakatsu Isozaki, Daichi Kurihara
  • Patent number: 10420935
    Abstract: Disclosed is a voltage monitoring circuit for use in detecting if a voltage supplied to current-generating circuit is sufficient to allow the current-generating circuit to produce a desired current. In one embodiment the circuit is designed for use in an implantable device that is configured to deliver therapeutic pulses to a patient. The voltage monitoring circuit is configured to produce a signal if a supplied voltage is insufficient to allow a current-generating circuit to deliver a requested current to a set of electrodes. In one embodiment, the voltage monitoring circuit detects a change in a difference between the voltage at a node in the current-generating circuit and the supplied voltage.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: September 24, 2019
    Assignee: Nevro Corp.
    Inventors: Paul Illegems, Jon Parker
  • Patent number: 10420480
    Abstract: The present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing surgical procedures and assessments involving the use of neurophysiology.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: September 24, 2019
    Assignee: NuVasive, Inc.
    Inventors: Richard W. Schermerhorn, Eric Finley, Adam Azzara, Dmitry Novikov, James E. Gharib
  • Patent number: 10391315
    Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating neural tissue where the neural tissue including dorsal horn tissue or nerve root tissue, a neural modulation generator, and a controller. The neural modulation generator may be configured to use at least some electrodes to generate a modulation field. The neural modulation generator maybe configured to use a programmed modulation parameter set to promote uniformity of the modulation field in the dorsal horn tissue. The controller may be configured to control the neural modulation generator to generate the modulation field in pulse trains of at least two pulses.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: August 27, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Changfang Zhu
  • Patent number: 10384068
    Abstract: A system for treating chronic inflammation may include an implantable microstimulator, a wearable charger, and optionally an external controller. The implantable microstimulator may be implemented as a leadless neurostimulator implantable in communication with a cervical region of a vagus nerve. The microstimulator can address several types of stimulation including regular dose delivery. The wearable charger may be worn around the subject's neck to rapidly (<10 minutes per week) charge an implanted microstimulator. The external controller may be configured as a prescription pad that controls the dosing and activity of the microstimulator.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: August 20, 2019
    Assignee: SetPoint Medical Corporation
    Inventors: Michael A. Faltys, Jesse M. Simon, Yiming Liu
  • Patent number: 10376696
    Abstract: Devices, systems and methods are disclosed that allow a patient to self-treat a medical condition, such as migraine headache, by electrical noninvasive stimulation of a vagus nerve. The system comprises a stimulator that is applied to the surface of the patient's neck. The device housing transmits data to a patient interface device such as a mobile phone or computer relating to the status of a stimulation session. The interface device in turn may communicate with a database contained within other computers, via a network or the internet. The system is designed to address problems that arise particularly during self-treatment, when a medical professional is not present.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: August 13, 2019
    Assignee: Electrocore, Inc.
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
  • Patent number: 10359856
    Abstract: A VR tactile feedback system includes a hub, a feedback point wearable device set, a bionic tendon set, a motor device, and an MCU. The feedback point wearable device set includes multiple wearable devices which can be put on multiple feedback parts of a user. The bionic tendon set includes multiple bionic tendons each having a first end connected to a corresponding wearable device and a second end accommodated in the hub. The motor device is configured to apply multiple pulling forces to the multiple bionic tendons. The MCU is configured to instruct the motor device to adjust the values of the pulling forces according to VR content, thereby providing a corresponding tactile feedback at each feedback part of the user.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: July 23, 2019
    Assignee: ACER INCORPORATED
    Inventors: Jia-Yu Lin, Chih-Chiang Chen
  • Patent number: 10347053
    Abstract: Techniques disclosed herein involve adaptively or dynamically displaying virtual objects in a virtual reality (VR) environment, and representations, within the VR environment, of physical objects in the physical environment, i.e., outside the VR environment, in order to alert users within the VR environment. For example, if a projected movement of a user indicates that the user will move close to a physical object in the physical world, the representation of the physical object changes from an un-displayed state, in which the physical object is not visible in the VR environment, to a displayed state in which the physical object is at least partially depicted inside the VR environment. In this way, what is displayed inside the VR environment can include both virtual objects as well representations of physical objects from the physical space.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: July 9, 2019
    Assignee: GOOGLE LLC
    Inventors: Chris McKenzie, Adam Glazier, Clayton Woodward Bavor, Jr.
  • Patent number: 10342974
    Abstract: A method for interferential current stimulation by complex active regions, in which the method is adapted to generate low frequency interference active regions formed of staggered electric flux lines by disposing electrodes to stimulate specific parts of a human body by supplying electricity is provided.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: July 9, 2019
    Inventor: Kou-Chang Hsieh
  • Patent number: 10335601
    Abstract: A neurostimulation system includes a programming control circuit and a user interface. The programming control circuit may be configured to generate a plurality of stimulation parameters controlling delivery of neurostimulation pulses according to one or more neurostimulation programs each specifying a pattern of the neurostimulation pulses. The user interface includes a display screen, a user input device, and a neurostimulation program circuit. The neurostimulation program circuit may be configured to allow for construction of one or more pulse trains (PTs) and one or more train groupings (TGs) of the one or more neurostimulation programs, and to allow for scheduling of delivery of the one or more neurostimulation programs, using the display screen and the user input device. Each PT includes one or more pulse blocks each including a plurality of pulses of the neurostimulation pulses. Each TG includes one or more PTs.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: July 2, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: David Ernest Wechter
  • Patent number: 10315034
    Abstract: The present disclosure provides a spinal cord stimulation (SCS) system. The system includes at least one SCS lead including a lead body, at least one distal electrode located at a distal end of the lead body, the at least one distal electrode configured to apply electrical stimulation to a stimulation target of a patient, and a pain reduction assembly coupled to the lead body and configured to reduce post-operation pain at an incision site associated with implantation of the at least one SCS lead. The system further includes a pulse generator coupled to the at least one SCS lead and configured to control electrical stimulation delivered to the patient via the at least one SCS lead.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: June 11, 2019
    Assignee: PACESETTER, INC.
    Inventors: Wenbo Hou, Alexander Kent, Edward Karst, Gene A. Bornzin, Riddhi Shah, Caroline Jordan, Yelena Nabutovsky
  • Patent number: 10307589
    Abstract: The present invention is a system and method for providing an electrical stimulation signal to condition the pelvic wall muscles of a user and demonstrate to the user the proper muscle usage. The system and method also provides a system for measuring the users muscle response. The system and method also provides an entertaining interaction environment which encourages the user to perform self-initiated conditioning exercises.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: June 4, 2019
    Inventor: Brent C. Reider
  • Patent number: 10292636
    Abstract: A device for evaluation of suicide risk of a person. A measuring unit measures electrodermal activity in fingers of the person to detect depressed persons who are at risk for suicide. The measuring unit is arranged to transmit a sound signal or tone to the person and to provide a signal for analysis of the electrodermal activity from the person. A measuring module measures orientation reactions in the form of blood volume variations of the person, preferably by a phtophletysmographic method peripherally in the fingers and/or centrally in the frontal lobe of the brain through the forehead, and changes in the pulse rate of the test person.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: May 21, 2019
    Assignee: EMOTRA AB
    Inventor: Lars-Håkan Thorell
  • Patent number: 10279174
    Abstract: A device for transcutaneous electrical stimulation is provided. The device comprises circuitry configured to generate transcutaneous stimulation signals. The device also comprises a first signal output component for electrically connecting to a first electrode connector to deliver generated transcutaneous stimulation signals. The first signal output component comprises a first four-pole electrical connector part. The device further comprises a second signal output component for electrically connecting to a second electrode connector to deliver generated transcutaneous stimulation signals. The second signal output component comprises a second four-pole electrical connector part. The device further comprises a controller to selectively control output of the stimulation signals to selected pairs of poles across the first and second four-pole electrical connector parts.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 7, 2019
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, Rod Wiebenga, David Fisher
  • Patent number: 10279167
    Abstract: The present disclosure provides a closed-loop system for real-time control of epidural and/or subdural electrical stimulation comprising electrodes for applying to a subject neuromodulation with adjustable stimulation parameters, the electrodes being operatively connected with a real-time monitoring component comprising sensors continuously acquiring feedback signals from said subject, said signals being neural signals and/or signals providing features of motion of said subject, said system being operatively connected with a signal processing device receiving said feedback signals and operating real-time automatic control algorithms, said signal processing device being operatively connected with the electrodes said and providing the electrodes with new stimulation parameters, with minimum delay. The system of the disclosure improves consistency of walking in a subject with a neuromotor impairment.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: May 7, 2019
    Assignee: Ecole Polytechnique Federale De Lausanne (EPFL)
    Inventors: Grégoire Courtine, Nikolaus Wenger, Eduardo Martin Moraud, Silvestro Micera, Marco Bonizzato
  • Patent number: 10252085
    Abstract: An apparatus, system, and method for neurostimulation by high frequency ultrasound. In one embodiment, an apparatus includes a pulse generator, an ultrasound transducer coupled to the pulse generator, and an implantable stimulator. The implantable stimulator may include a piezoelectric element configured to convert ultrasound signals from the ultrasound transducer into electrical signals, a rectifier configured to convert alternating current from the piezoelectric element to a monophasic current, a capacitor coupled to the rectifier, and a first electrode and a second electrode coupled to the rectifier and capacitor and configured to transmit the monophasic current to body tissue. In addition, the apparatus may include a current-limiting circuit configured to limit the amount of current transmitted to the body tissue.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: April 9, 2019
    Assignee: Arizona Board of Regents on Behalf of Arizona State University
    Inventors: Bruce C. Towe, Daniel Gulick
  • Patent number: 10245433
    Abstract: A spinal cord modulation system is disclosed. While in one embodiment the system is used for the treatment of pain, other embodiments are also provided. In particular embodiments, the spinal cord modulation system generates and delivers an electrical therapy signal at a frequency in the range of from about 1.5 kHz to about 100 kHz to address pain without creating unwanted sensory and/or motor side effects. The system may further include various signal delivery devices to deliver the therapy signal to a patient's spinal cord region.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 2, 2019
    Assignee: Nevro Corp.
    Inventors: Konstantinos Alataris, Andre B. Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R. Thacker
  • Patent number: 10195447
    Abstract: A method of electrostimulation of a group of one or more target muscles of a subject is provided, the method comprising in a first step applying to the subject an electrical pulse having a duration of at least 0.5 milliseconds and an intensity below that effective in stimulating contraction of the target muscles of the subject; and in a second step applying one or more electrical pulses at an intensity sufficient to stimulate contraction of the target muscles of the subject. An apparatus for the electrostimulation of the muscles of a subject employing the aforementioned method is also provided.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: February 5, 2019
    Assignee: Actegy Limited
    Inventors: David Paul Sumners, Katya Nikolova Mileva
  • Patent number: 10195455
    Abstract: A therapeutic or diagnostic system comprises a non-invasive brain stimulation device (such as a TMS stimulation device) or other neuromodulation device configured to stimulate a patient's brain or nervous system by emitting electromagnetic pulses according to stimulation parameters, such as a pulse frequency or burst repetition frequency or other parameters, that provides surprising improvements in responsiveness and/or may require only a relatively short train of pulses to achieve high efficacy. In particular, stimulation pulses may be delivered at a frequency of between 12 and 40 Hertz with a 3 to 5 ratio as compared with burst repetition frequency, or at other specific patterns within that range. The stimulation parameters may be pre-stored and customized to individual patients, being identified through an automated search routine during which patient feedback is monitored. A user interface may be provided to allow an operator to conveniently select the appropriate parameters for the desired treatment.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: February 5, 2019
    Inventor: William F. Stubbeman
  • Patent number: 10195434
    Abstract: Described herein are systems and methods for the treatment of pain using electrical nerve conduction block (ENCB). Contrary to other methods of pain treatment, the ENCB can establish a direct block of neural activity, thereby eliminating the pain. Additionally, the ENCB can be administered without causing electrochemical damage. An example method can include: placing at least one electrode contact in electrical communication with a region of a subject's spinal cord; applying an electrical nerve conduction block (ENCB) to a nerve in the region through the at least one electrode contact; and blocking neural activity with the ENCB to reduce the pain or other unwanted sensation in the subject.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: February 5, 2019
    Assignee: Case Western Reserve University
    Inventors: Niloy Bhadra, Narendra Bhadra, Kevin L. Kilgore, Scott Lempka, Jesse Wainright, Tina Vrabec, Manfred Franke
  • Patent number: 10179238
    Abstract: A peripheral nerve stimulator can be used to stimulate a peripheral nerve to treat essential tremor, Parkinsonian tremor, and other forms of tremor. The stimulator can have electrodes that are placed circumferentially around the patient's wrist or arm. Specific nerves in the wrist or arm can be targeted by appropriate spacing of the electrodes. Positioning the electrodes on generally opposing sides of the target nerve can result in improved stimulation of the nerve. The stimulation pattern may alternate between the nerves. Improved stimulation algorithms can incorporate tremor feedback, external data, predictive adaptation, and long-term monitoring data.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: January 15, 2019
    Assignee: Cala Health, Inc.
    Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Hamner, Paula Chidester, Scott L. Delp, Terence D. Sanger, David Klein
  • Patent number: 10143846
    Abstract: A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. The components of the controller and microstimulator may be implemented in a single unit or in separate devices. When implemented separately, the controller and microstimulator may communicate wirelessly or via a wired connection. The microstimulator may generate pulses from a controller signal and apply the signal via one or more electrodes to an anatomical target. The microstimulator may not have any intelligence or logic to shape or modify a signal. The microstimulator may be a passive device configured to generate a pulse based on a signal received from the controller. The microstimulator may shape or modify a signal. Waveforms having different frequency, amplitude and period characteristics may stimulate different anatomical targets in a patient.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: December 4, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Douglas Michael Ackermann, Daniel Palanker, James Donald Loudin, Garrett Cale Smith, Victor Wayne McCray, Brandon McNary Felkins
  • Patent number: 10137299
    Abstract: In various embodiments, methods are provided for applying transcutaneous and/or epidural spinal cord stimulation with and without selective pharmaceuticals to restore voluntary control of hand function in tetraplegic subjects.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: November 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Daniel C. Lu, V. Reggie Edgerton, Roland R. Roy, Yury P. Gerasimenko
  • Patent number: 10118030
    Abstract: A neural probe system having a single guide tube that is inserted into neural tissue and from which a number of neural probes can be deployed is described. Each probe is deployable into tissue along a desired trajectory. This is done by supporting the electrode array on a spring tape-type carrier that maintains axial stiffness once the neural probe has deployed out a channel in the guide tube. That way, a target neural tissue is bounded by an increased number of neural probes while minimizing trauma to surrounding body tissue.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: November 6, 2018
    Assignee: NeuroNexus Technologies, Inc.
    Inventors: David S. Pellinen, Bencharong Suwarato, Rio J. Vetter, Jamille Farraye Hetke, Daryl R. Kipke
  • Patent number: 10105540
    Abstract: Apparatus is provided, comprising: (a) an implantable excitation unit, configured to induce action potentials in a nerve of a subject by applying an excitatory current; (b) an implantable blocking unit, configured to block the induced action potentials from propagating along the nerve by applying a blocking current; and (c) an extracorporeal controller, comprising circuitry configured: (i) to wirelessly drive the excitation unit to apply the excitatory current, (ii) in a first mode, to wirelessly drive the blocking unit to apply the blocking current while not driving the excitation unit to apply the excitatory current, (iii) in a second mode, to wirelessly drive the blocking unit to apply the blocking current while driving the excitation unit to apply the excitatory current, and (iv) to wirelessly alter a parameter of the blocking current, based on sensing performed while the extracorporeal controller is in the second mode.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: October 23, 2018
    Assignee: BLUEWIND MEDICAL LTD.
    Inventors: Gur Oron, Bar Eytan, Eran Benjamin, Anton Plotkin, Yossi Gross
  • Patent number: 10099052
    Abstract: The invention is a multi-channel physiotherapy device, which is fitted with an electrical source, a power supply unit, a photo-coupler, a microprocessor, and an electrode. It is characterized in that the electrical source is connected to a single power supply unit, the power supply unit is connected to the microprocessor, and the microprocessor is connected to the photo-couplers and, through the photo-couplers and the channels, to the electrodes, the number of which is at least approximately equal to the number of photo-couplers and channels.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: October 16, 2018
    Inventor: Janos Papp
  • Patent number: 10092762
    Abstract: An integrated electromyography (EMG) and signal/stimulation generation clinician programmer may be coupled with an implantable temporary or permanent lead in a patient and at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. Generally, the integrated clinician programmer may comprise a portable housing, a signal/stimulation generator, and EMG signal processor, and a graphical user interface. The signal/stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The EMG signal processor may be disposed within the housing and configured to record a stimulation-induced EMG motor response for each test stimulation via the at least one EMG sensing electrode. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or a keyboard, mouse, or the like.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: October 9, 2018
    Assignee: AXONICS MODULATION TECHNOLOGIES, INC.
    Inventors: Guangqiang Jiang, John Woock, Dennis Schroeder, Eric Schmid
  • Patent number: 10076459
    Abstract: Methods and systems for lift monitoring are described. In one embodiment, a first operation signal may be received from a first relay coupled to an electro-mechanical patient lift when the electro-mechanical patient lift is being operated in a first position. A second operation signal may be received from a second relay coupled to the electro-mechanical patient lift when the electro-mechanical patient lift is being operated in a second position. A determination of whether a lift qualification threshold is met may be based on the receiving of the first operation signal and the second operation signal. An occurrence of a lift may be recorded when a determination is made that the lift qualification threshold is met. Additional methods and systems are disclosed.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: September 18, 2018
    Assignee: WESTROCK SOLUTIONS, LLC
    Inventors: James D. Todd, Thomas Hollinger, Christopher F. Fangrow
  • Patent number: 10052484
    Abstract: Devices and methods for improving the coupling between the soft palate and the genioglossus. This may be accomplished, for example, but shortening or stiffening the palatoglossal arch. Improved coupling between the soft palate and the genioglossus may be beneficial to a patient suffering from obstructive sleep apnea (OSA) as a stand-alone procedure, or in combination procedures and devices that cause anterior displacement of the tongue such as hypoglossal nerve stimulation, genioglossus advancement surgery, mandibular advancement surgery, mandibular advancement (oral) appliances, etc.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: August 21, 2018
    Assignee: Cyberonics, Inc.
    Inventors: Stephen Bolea, Wondimeneh Tesfayesus, John Beck, Thomas Hoegh, Robert Atkinson, Sidney Hauschild
  • Patent number: 10016594
    Abstract: A method for implanting a neurostimulation lead within a patient includes measuring impedances of electrodes on the lead in order to correctly position the lead relative to a target tissue region. The electrodes are circumferentially segmented electrodes that are spaced from each other about the longitudinal axis of the lead. When the difference between the impedances of the electrodes exceeds a threshold value, the lead is in the correct position. In accordance with another embodiment, impedance measurements are used to select which one of the electrodes is closest to the target tissue region. By determining which electrode has the highest impedance and which electrode has the lowest impedance, the type of tissue adjacent to each electrode can be determined based on the conductivity properties of the tissue. The target tissue region may be a spinal cord, a posterior longitudinal ligament, white matter, or gray matter.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: July 10, 2018
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Kerry Bradley
  • Patent number: 10010713
    Abstract: Disclosed herein is a method of treating a disease, comprising: (a) implanting an array of electrodes on one or more targeted nerves and/or targeted muscles; and (b) treating the disease by selectively stimulating the one or more targeted nerves and/or targeted muscles through electrical pulses delivered from the array. Also disclosed herein is a device, comprising a plurality of electrodes that have the capacity to be inserted in a facial nerve. Further disclosed herein is a method of treating facial paralysis and/or damage in a subject, comprising: (a) detecting the level of contraction of individual muscles on a healthy, non-paralyzed side of the face of the subject; and (b) treating facial paralysis by a direct targeted stimulation of the corresponding muscles or nerve fibers on a paralyzed side of the face of the subject.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: July 3, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Harrison W. Lin
  • Patent number: 10004898
    Abstract: A system and method to treat neuromuscular conditions, including spinal cord injury, by what is characterized as dipole (two point) cortico-muscular stimulation. Two-point stimulation, with oppositely charged electrodes, allows pulsed, direct current to pass through the cortico-muscular pathway. The electrodes are placed on nerves, muscles, or a combination of both, that are on opposite sides of the spinal column, forming a current that passes across the spinal column. Further, an active electrode can be placed on the spinal column and a reference electrode can be placed outside the central nervous system. These methods improve functional recovery of the motor pathway.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: June 26, 2018
    Assignee: THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
    Inventors: Zaghloul Ahmed, Andrzej Wieraszko
  • Patent number: 9993651
    Abstract: A system for treating chronic inflammation may include an implantable microstimulator, a wearable charger, and optionally an external controller. The implantable microstimulator may be implemented as a leadless neurostimulator implantable in communication with a cervical region of a vagus nerve. The microstimulator can address several types of stimulation including regular dose delivery. The wearable charger may be worn around the subject's neck to rapidly (<10 minutes per week) charge an implanted microstimulator. The external controller may be configured as a prescription pad that controls the dosing and activity of the microstimulator.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: June 12, 2018
    Assignee: SetPoint Medical Corporation
    Inventors: Michael A. Faltys, Jesse M. Simon, Yiming Liu
  • Patent number: 9987187
    Abstract: Disclosed herein are an apparatus and method for controlling smart wear. The apparatus for controlling smart wear includes a motion capture unit, an error information unit, a motion estimation unit, and an actuation unit. The motion capture unit captures a motion of a user using sensors included in the smart wear. Then error information unit generates user error information using reference motion information and the results of the motion capture. The motion estimation unit estimates a subsequent motion of the user using the user error information. The actuation unit controls the smart wear of the user in real time using the estimated subsequent motion and the user error information.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: June 5, 2018
    Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Hyung-Il Park, Byoung-Gun Choi, Sung-Weon Kang, Chang-Hee Hyoung, In-Gi Lim, Tae-Wook Kang, Jung-Hwan Hwang, Kyung-Soo Kim, Jung-Bum Kim, Sung-Eun Kim, Kyung-Hwan Park, Tae-Young Kang
  • Patent number: 9980645
    Abstract: A method and an electrode for monitoring electrical activity in a nerve are provided along with a method of fabricating such an electrode. The electrode includes a cuff formed from a chronically-implantable material that, when implanted, extends at least partially around an external periphery of the nerve. A plurality of contacts are supported by the cuff to be arranged adjacent to different regions of the nerve distributed along a transverse direction of the nerve when the cuff is implanted. A multiplexer is coupled to the cuff to be implanted for receiving electrical signals introduced to the contacts by the nerve and multiplexing, in vivo, the electrical signals to be transmitted to an external receiver over a shared communication channel.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: May 29, 2018
    Assignee: Case Western Reserve University
    Inventors: Dominique M. Durand, Brian Wodlinger
  • Patent number: 9974959
    Abstract: An electrical stimulation system includes a control module that provides electrical stimulation signals to an electrical stimulation lead coupled to the control module for stimulation of patient tissue. The system also includes a sensor to be disposed on or within the body of the patient and to measure a biosignal; and a processor to communicate with the sensor to receive the biosignal and to generate an adjustment to one or more of the stimulation parameters based on the biosignal. The adjustment can be configured and arranged to steer the electrical stimulation signals to stimulate a region of the patient tissue that is different, at least in part, from a region of the patient tissue stimulated prior to the adjustment. Alternatively or additionally, the biosignal is indicative of a particular patient activity and the adjustment is a pre-determined adjustment selected for the particular patient activity.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Sridhar Kothandaraman
  • Patent number: 9974951
    Abstract: A system and method to treat neuromuscular conditions, including spinal cord injury, by what is characterized as dipole (two point) cortico-muscular stimulation. Two-point stimulation, with oppositely charged electrodes, allows pulsed, direct current to pass through the cortico-muscular pathway. The electrodes are placed on nerves, muscles, or a combination of both, that are on opposite sides of the spinal column, forming a current that passes across the spinal column. Further, an active electrode can be placed on the spinal column and a reference electrode can be placed outside the central nervous system. These methods improve functional recovery of the motor pathway.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: May 22, 2018
    Assignee: THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
    Inventors: Zaghloul Ahmed, Andrzej Wieraszko
  • Patent number: 9968774
    Abstract: A method of using of a pair of prior art hand-held device known as the Dolphin Neurostim™ to supply minute, concentrated micro-current impulses to the perimeters of cranial sutures for the purpose of tissue diagnosis (through ohm resistance measurement), promotion pain management (through sympathetic deregulation of the Autonomic Nervous System. The micro-current stimulus (therapy) is delivered through a tiny metallic spring tip (probe) ideally suited for location (detection) of specific treatment points (which have the cellular characteristic of lowered skin resistance). The device concurrently detects, measures, and stimulates therapeutically active treatment points located beside sutures. Once detected, the device is activated to deliver a concentrated (DC) micro-current stimulus through the suture tissue to another identical device located (mirrored) on the opposing side of the suture.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 15, 2018
    Assignee: Center for Pain and Stress Research, Ltd.
    Inventor: Bruce Hocking
  • Patent number: 9968773
    Abstract: A method using a prior art hand-held device known as the Dolphin Neurostim™ to supply minute, concentrated micro-current impulses to the (outside) perimeters of scar tissue for the purpose of tissue diagnosis (through ohm resistance measurement), promotion of scar tissue repair (through electrical repolarization), and pain management (through sympathetic deregulation of the Autonomic Nervous System. The micro-current stimulus (therapy) is delivered through a tiny metallic spring tip (probe) ideally suited for location (detection) of specific treatment points (which have the cellular characteristic and lowered skin resistance). The device is activated to deliver a concentrated (DC) micro-current stimulus through the scar/suture tissue to another identical device located (mirrored) on the opposing side of the scar/suture.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 15, 2018
    Assignee: Center for Pain and Stress Research, Ltd
    Inventor: Bruce Hocking
  • Patent number: 9955906
    Abstract: The present invention relates to a system and a method for selecting an audio file using motion data from a mobile computing device connected to or held by a user, the mobile computing device comprising or coupled to motion sensors. The method comprising steps of moving the mobile computing device, obtaining motion data from the motion sensors, computing from the motion data step data based on a number of steps taken by the user in a specific period of time, computing a metronome beat based on the step data and generating a metronome beat file, selecting a stored audio file having a predefined beat parameter matching the metronome beat of the metronome beat file, and playing the audio file.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: May 1, 2018
    Assignee: Beats Medical Limited
    Inventors: Ciara Lourda Clancy, Cianan Colm Clancy, Wui Mei Chew
  • Patent number: 9958943
    Abstract: The present invention concerns a method and apparatus for the modulation of an acoustic field for providing tactile sensations. A method of creating haptic feedback using ultrasound is provided. The method comprises the steps of generating a plurality of ultrasound waves with a common focal point using a phased array of ultrasound transducers, the common focal point being a haptic feedback point, and modulating the generation of the ultrasound waves using a waveform selected to produce little or no audible sound at the haptic feedback point.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: May 1, 2018
    Assignee: Ultrahaptics IP Ltd
    Inventors: Benjamin John Oliver Long, Thomas Andrew Carter, Sriram Subramanian
  • Patent number: 9950173
    Abstract: A neuromodulation system includes modulation output circuitry and control circuitry. The modulation output circuitry may be configured to deliver therapeutic electrical energy including therapeutic sub-threshold electrical energy and therapeutic a super-threshold electrical energy. The sub-threshold electrical energy is below a patient-perception threshold and the super-threshold electrical energy is above the patient-perception threshold. The patient-perception threshold is a boundary below which a patient does not sense delivery of the electrical energy and above which the patient does sense delivery of the electrical energy. The control circuitry is configured to control the modulation output circuitry to deliver the therapeutic electrical energy using alternating cycles of the sub-threshold electrical energy below the patient-perception threshold and the super-threshold electrical energy above the patient-perception-threshold.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: April 24, 2018
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Que T. Doan
  • Patent number: 9937350
    Abstract: An embodiment relates to a method for delivering a vagal stimulation therapy to a vagus nerve, including delivering a neural stimulation signal to non-selectively stimulate both afferent axons and efferent axons in the vagus nerve according to a predetermined schedule for the vagal stimulation therapy, and selecting a value for at least one parameter for the predetermined schedule for the vagal stimulation therapy to control the neural stimulation therapy to avoid physiological habituation to the vagal stimulation therapy. The parameter(s) include at least one parameter selected from the group of parameters consisting of a predetermined therapy duration parameter for a predetermined therapy period, and a predetermined intermittent neural stimulation parameter associated with on/off timing for the intermittent neural stimulation parameter.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: April 10, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Imad Libbus, Andrew P. Kramer
  • Patent number: 9884195
    Abstract: The present invention relates a system that can configure a stimulus for functional electrical stimulation (“FES”) to maintain a constant muscle force while delaying the onset of muscle fatigue and a related method of use. The stimulus can be delivered to a nerve via a set of multiple electrode contacts according to a stimulation parameter that maximizes a joint moment associated with the stimulus and minimizes the overlap between pairs of contacts. The joint moment can be related to the muscle force, and the overlap can be related to the onset of muscle fatigue.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: February 6, 2018
    Assignee: Case Western Reserve University
    Inventors: Lee Fisher, Ronald Triolo, Dustin J. Tyler
  • Patent number: 9884191
    Abstract: An implantable neurostimulator system is disclosed, the neurostimulator system comprising a hollow cylindrical electronics enclosure having a top, a bottom, and a side; a coil extending from a first part of the electronics enclosure; and at least one electrode operatively connected to the electronics enclosure.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: February 6, 2018
    Assignee: ImThera Medical, Inc.
    Inventors: Paul M. Meadows, Marcelo G. Lima, Stanley R. Craig